209 results
SD
EX-1.01
WST
West Pharmaceutical Services, Inc.
30 May 19
Conflict minerals disclosure
3:57pm
manufacturing and analytical lab services.
Supply Chain
In 2018, consistent with previous years, we determined that the only product for which West sourced … that produce the 3TGs within our supply chain and do not control any mineral reserves. Thus, any 3TGs that are potentially present in any of our
SD
EX-1.01
WST
West Pharmaceutical Services, Inc.
25 May 23
Conflict minerals disclosure
4:12pm
, as well as contract manufacturing, analytical lab services and integrated solutions.
Supply Chain
This Report relates to products: (i) for which 3TGs … are necessary to the functionality or production of the Covered Products. Our supply chain with respect to the Covered Products is complex, and there are many
SD
EX-1.01
WST
West Pharmaceutical Services, Inc.
26 May 22
Conflict minerals disclosure
12:00am
systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions.
Supply Chain
In 2021 … parties. We do not have direct relationships with smelters or refiners that produce the 3TGs within our supply chain and do not control any mineral
SD
EX-1.01
WST
West Pharmaceutical Services, Inc.
28 May 21
Conflict minerals disclosure
7:16am
delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions.
Supply Chain
In 2020, consistent with previous … third parties. We do not have direct relationships with smelters or refiners that produce the 3TGs within our supply chain and do not control any
SD
EX-1.01
WST
West Pharmaceutical Services, Inc.
25 May 18
Conflict minerals disclosure
1:46pm
manufacturing and analytical lab services.
Supply Chain
In 2017, consistent with previous years, we determined that the only product for which West sourced … that produce the 3TGs within our supply chain and do not control any mineral reserves. Thus, any 3TGs that are potentially present in any of our
SD
EX-1.01
tkw0rg
28 May 20
Conflict minerals disclosure
4:16pm
8-K
EX-99.1
y5542ll5
12 May 22
West Announces Executive Leadership Appointments
4:32pm
8-K
4a55r 8yk5ywkbq64w9
12 May 22
West Announces Executive Leadership Appointments
4:32pm
8-K
EX-99.1
4u9 onm56czvef7q17hj
2 Aug 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
fsv3fol3dt2fh
13 Mar 08
Regulation FD Disclosure
12:00am
8-K
EX-99
m8hvln6xnv9
2 Aug 07
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
hu12batckwqie8xl
28 Apr 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99
9lsqg96az rmu2cb9wcy
4 Oct 07
Regulation FD Disclosure
12:00am
8-K
EX-99.1
abrpawpyh8c r0g6
1 Aug 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
qbufiz coen3
13 Mar 08
Regulation FD Disclosure
12:00am
8-K
EX-99.1
11rhchfqwz3
19 Oct 07
West Pharmaceutical Services Issues Statement on Exubera
12:00am
8-K
EX-99.1
fau thmkx
6 Jun 12
Regulation FD Disclosure
12:00am
8-K
EX-99
j9zl404bbjql6ddl
19 Jul 06
Results of Operations and Financial Condition
12:00am
SC TO-I/A
EX-99
53qr3cd
6 Jun 12
Issuer tender offer statement (amended)
12:00am